This forum celebrated an exciting new research initiative: the UC Berkeley Synthetic Biology Institute (SBI).

The institute will address the science, technology, and big-picture challenges of engineering biological solutions, drawing on collaborations among faculty, students, and active industry partners. We believe this work will enable substantial advances in medicine, materials, energy, food production, and a host of other arenas.

Speakers:

• S. Shankar Sastry, Dean, College of Engineering, UC Berkeley
• Richard A. Mathies, Dean, College of Chemistry, UC Berkeley
• William P. Sullivan, President and CEO, Agilent Technologies

Panelists:

• Paul Berg, Nobel Laureate and Cahill Professor Emeritus, Biochemistry, Stanford University
• Douglas Cameron, Founder and Managing Director, Alberti Advisers
• Jay Keasling, Howe Distinguished Professor, Chemical and Biomolecular Engineering, UC Berkeley
• Darlene Solomon, Chief Technical Officer, Agilent Technologies
• Matthew Tirrell, Silverman Professor and Chair, Bioengineering, UC Berkeley